Researchers evaluated the association between the use of various hormonal contraceptives and the risk for surgically treated intracranial meningioma.
Researchers are advancing NES/T hormonal gel and DMAU through clinical trials. These methods suppress sperm production via ...
Mohr Marketing’s “Medical-First” Depo-Provera program screens for confirmed meningioma diagnoses, ensuring firms receive ...
Use BBC.com or the new BBC App to listen to BBC podcasts, Radio 4 and the World Service outside the UK.
Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...
A migraine attack is not just a “bad headache”. Migraine is a debilitating neurological condition which can cause nausea, vomiting, and sensitivity to light or sound, in addition to severe headaches.
Eli Lilly and Company today announced the U.S. Food and Drug Administration (FDA) approved a label expansion for Zepbound® (tirzepatide) to include the four-dose single-patient use KwikPen® that ...
Losing weight is no longer just about discipline and diet. GLP-1 drugs are becoming the "fast track" path to weight loss, redefining body and beauty standards for women. | Mind and Body, Lifestyle, ...
FDA grants breakthrough status to Rybrevant Faspro for recurrent or metastatic HPV-negative head and neck cancer after prior therapy.
At 36 weeks in the TOGETHER-PsO study, concomitant Taltz and Zepbound met primary endpoint of superiority vs. Taltz monotherapy in achieving complete skin clearance ...